Lyell Immunopharma LYEL
NASDAQ LYEL
$9.41 -0.38 (-3.88%)
At close: Oct 1, 2026 · 4:00 PM EDT

Lyell Immunopharma (LYEL) Other Non-Current Liabilities (2020 - 2026)

Updated

Lyell Immunopharma (LYEL) reported Other Non-Current Liabilities of $537,000 for Q2 2026, down 90.3% from $5.53 million a year earlier but up 1.9% from the prior quarter.

Analysis

Lyell Immunopharma (LYEL) Other Non-Current Liabilities (2020 - 2026) Analysis & Trends

At the end of FY2025, Lyell Immunopharma posted Other Non-Current Liabilities of $517,000, down 93.2% from FY2024.

  • Other Non-Current Liabilities has a five-year compound annual growth rate of -0.6% (FY2020 to FY2025).
  • By year, Other Non-Current Liabilities came in at $7.6 million in FY2024 (+107.4%), $3.66 million in FY2023 (-10.9%), $4.11 million in FY2022 (-9.9%) and $4.57 million in FY2021 (+758.3%).
  • Five-year quarterly Other Non-Current Liabilities spans a low of $517,000 in Q4 2025 and a high of $7.6 million in Q4 2024.
  • Year over year, Other Non-Current Liabilities has now declined in each of the last four quarters, with an average decline of 7.2% over the last eight quarters.
  • The high point for year-over-year Other Non-Current Liabilities in five years was Q4 2021 (growth of 758.3%); the low point was Q4 2025 (a decline of 93.2%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $527,000 (Q1 2026), $517,000 (Q4 2025) and $2.68 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Lyell Immunopharma 229.06 Mn 229.06 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 537,000.00
Mar 31, 2026 527,000.00
Dec 31, 2025 517,000.00
Sep 30, 2025 2.68 Mn
Jun 30, 2025 5.53 Mn
Mar 31, 2025 6.39 Mn
Dec 31, 2024 7.60 Mn
Sep 30, 2024 3.57 Mn
Jun 30, 2024 3.44 Mn
Mar 31, 2024 3.55 Mn
Dec 31, 2023 3.66 Mn
Sep 30, 2023 3.78 Mn
Jun 30, 2023 3.89 Mn
Mar 31, 2023 4.00 Mn
Dec 31, 2022 4.11 Mn
Sep 30, 2022 4.23 Mn
Jun 30, 2022 4.34 Mn
Mar 31, 2022 4.45 Mn
Dec 31, 2021 4.57 Mn
Sep 30, 2021 5.01 Mn
API Access

Lyell Immunopharma Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=LYEL&period=max&api_key=YOUR_API_KEY